Process for treating arabinoxylan-containing substrate

US10954499B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10954499-B2
Application numberUS-201916281926-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2019
Priority dateApr 26, 2005
Publication dateMar 23, 2021
Grant dateMar 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.

First claim

Opening claim text (preview).

The invention claimed is: 1. An industrial process for treating an arabinoxylan-containing substrate, comprising: contacting the arabinoxylan-containing substrate with a polypeptide having arabinofuranosidase activity, wherein the polypeptide having arabinofuranosidase activity is a polypeptide with at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 4 with modifications selected from the group consisting of: deletions of 1 to 30 amino acid residues; insertions of up to 25 amino acid residues; conservative substitutions of basic, acidic, polar, hydrophobic, aromatic and small amino acids, wherein the small amino acids are selected from the group consisting of: glycine, alanine, serine, threonine and methionine; and combinations thereof. 2. The process of claim 1 , wherein the polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 4. 3. The process of claim 1 , wherein the polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 4. 4. The process of claim 1 , wherein the polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 4. 5. The process of claim 1 , wherein the polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 4. 6. The process of claim 1 , wherein the polypeptide comprises the mature polypeptide of SEQ ID NO: 4. 7. The process of claim 1 , wherein the polypeptide is encoded by a nucleic acid sequence which hybridizes under high stringency conditions with the full-length complement of the nucleic acid sequence of nucleotides 46 to 1974 of SEQ ID NO: 3; wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/mL sheared and denatured salmon sperm DNA, and 50% formamide for high stringency, following standard Southern blotting procedures, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C. 8. The process of claim 1 , wherein the polypeptide is encoded by a nucleic acid sequence which hybridizes under very high stringency conditions with the full-length complement of the nucleic acid sequence of nucleotides 46 to 1974 of SEQ ID NO: 3; wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/mL sheared and denatured salmon sperm DNA, and 50% formamide for high stringency, following standard Southern blotting procedures, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C. 9. The process of claim 1 , wherein the polypeptide has a deletion from the amino and/or carboxyl terminus of the mature polypeptide of SEQ ID NO: 4 and has at least 430 amino acids of the mature polypeptide of SEQ ID NO: 4. 10. The process of claim 1 , wherein the process is for producing fuel ethanol from cellulose containing biomass. 11. The process of claim 1 , wherein the process is for producing fuel and/or potable ethanol from starch. 12. The process of claim 1 , wherein the process is for mashing in beer production. 13. The process of claim 1 , wherein the process is for dough making. 14. The process of claim 1 , wherein the process is for manufacturing an animal feed product.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10954499B2 cover?
The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification C12N9/2402. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).